STATE STREET CORP - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 2 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$199,873
+15.7%
246,7570.0%0.00%
Q1 2023$172,730
-50.4%
246,757
-50.0%
0.00%
Q4 2022$348,420
-28.6%
493,514
+53.8%
0.00%
Q3 2022$488,000
+100.0%
320,984
+30.3%
0.00%
Q2 2022$244,000
-86.3%
246,284
-80.1%
0.00%
Q1 2022$1,778,000
-68.9%
1,234,706
+12.9%
0.00%
Q4 2021$5,710,000
-0.9%
1,093,823
+10.6%
0.00%
Q3 2021$5,764,000
-26.6%
988,684
+1.4%
0.00%
Q2 2021$7,858,000
+17.6%
974,924
+21.4%
0.00%
Q1 2021$6,683,000
+7.7%
803,236
-1.9%
0.00%
Q4 2020$6,207,000
-21.9%
818,877
+9.9%
0.00%
-100.0%
Q3 2020$7,945,000
-28.6%
745,301
+1.5%
0.00%0.0%
Q2 2020$11,130,000
+114.9%
734,192
+18.1%
0.00%
Q1 2020$5,179,000
-48.9%
621,685
+3.7%
0.00%
-100.0%
Q4 2019$10,127,000
-7.1%
599,223
+2.1%
0.00%0.0%
Q3 2019$10,900,000
-13.8%
586,952
+6.2%
0.00%0.0%
Q2 2019$12,651,000
+11.6%
552,913
+2.5%
0.00%0.0%
Q1 2019$11,338,000
+90.7%
539,407
+4.3%
0.00%0.0%
Q4 2018$5,947,000
-51.0%
517,167
-2.2%
0.00%0.0%
Q3 2018$12,141,000
+5.0%
528,987
+2.0%
0.00%0.0%
Q2 2018$11,564,000
-3.5%
518,559
-1.1%
0.00%0.0%
Q1 2018$11,983,000
-11.1%
524,468
+1.9%
0.00%0.0%
Q4 2017$13,484,000
+24.0%
514,687
+6.3%
0.00%0.0%
Q3 2017$10,870,000
-16.3%
484,210
+1.9%
0.00%0.0%
Q2 2017$12,993,000
+27.1%
475,078
+12.5%
0.00%0.0%
Q1 2017$10,224,000
+18.4%
422,261
+1.5%
0.00%0.0%
Q4 2016$8,634,000
-17.2%
416,027
+8.7%
0.00%0.0%
Q3 2016$10,433,000
+96.1%
382,626
+3.5%
0.00%0.0%
Q2 2016$5,321,000
+0.4%
369,861
+0.2%
0.00%0.0%
Q1 2016$5,302,000
-31.4%
369,035
+2.6%
0.00%0.0%
Q4 2015$7,732,000
+36.1%
359,832
+2.4%
0.00%0.0%
Q3 2015$5,683,000
-36.7%
351,491
+1.1%
0.00%0.0%
Q2 2015$8,971,000
+13.6%
347,752
-0.9%
0.00%0.0%
Q1 2015$7,896,000
+23.2%
350,740
+5.0%
0.00%0.0%
Q4 2014$6,410,000
-5.1%
333,891
+6.2%
0.00%0.0%
Q3 2014$6,755,000
-15.2%
314,395
+2.6%
0.00%0.0%
Q2 2014$7,967,000
+148.4%
306,424
+108.3%
0.00%
Q1 2014$3,207,000
+96.3%
147,130
+9.8%
0.00%
Q4 2013$1,634,000
+4.9%
133,976
+15.4%
0.00%
Q3 2013$1,557,000
+413.9%
116,096
+210.4%
0.00%
Q2 2013$303,00037,4000.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders